Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01882569 · ClinicalTrials.gov registry record
Optimization of Time-of-Flight Mass Cytometry (CyTOF) Analysis for Evaluation of Immune Changes Following Surgery
A clinical trial, sponsored by Martin Angst.
- Completed
- Registry status
- 5
- Enrollment target
NCT01882569 is a clinical trial that has completed, run by Martin Angst. The registered enrollment target is 5 participants.
The verdict
NCT01882569 has completed, sponsored by Martin Angst.
- COMPLETED
- Registry status
- 5 participants
- Enrollment target
Study Summary
Surgical trauma triggers a massive inflammatory response. Over time, both the innate and adaptive branches of the immune system are affected by surgical trauma. The purpose of this study is to use a single cell flow cytometry approach to characterize the cellular and molecular mechanisms involved in the inflammatory response to surgical trauma.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2012-05 |
| Est. Completion | 2014-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01882569
The ClinicalTrials.gov registry entry for NCT01882569 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Martin Angst, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01882569 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01882569 about?
NCT01882569 is a clinical study titled "Optimization of Time-of-Flight Mass Cytometry (CyTOF) Analysis for Evaluation of Immune Changes Following Surgery". Surgical trauma triggers a massive inflammatory response. Over time, both the innate and adaptive branches of the immune system are affected by surgical trauma. The purpose of this study is to use a single cell flow cytometry approach to characterize the cellular and molecular mechanisms involved in...
What is the current status of trial NCT01882569?
This trial is currently completed. The enrollment target is 5 participants. The study started on 2012-05. Estimated completion is 2014-09.
Who is sponsoring clinical trial NCT01882569?
This trial is sponsored by Martin Angst, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.